Esophageal Cancer-Derived Organoids to Predict Patients' Treatment Response

被引:0
|
作者
Du, L. [1 ,2 ]
Nagle, P. W. [1 ,3 ]
van Luijk, P. [1 ]
Plukker, J. [4 ]
Muijs, C. [1 ]
Coppes, R. P. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands
[2] Chongqing Univ, Dept Radiat Oncol, Canc Hosp, Chongqing, Peoples R China
[3] Univ Edinburgh, Queens Med Res Inst, Med Res Council MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2487
引用
收藏
页码:E227 / E227
页数:1
相关论文
共 50 条
  • [1] Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response
    Frappart, Pierre-Olivier
    Walter, Karolin
    Gout, Johann
    Beutel, Alica K.
    Morawe, Mareen
    Arnold, Frank
    Breunig, Markus
    Barth, Thomas F. E.
    Marienfeld, Ralf
    Schulte, Lucas
    Ettrich, Thomas
    Hackert, Thilo
    Svinarenko, Michael
    Roesler, Reinhild
    Wiese, Sebastian
    Wiese, Heike
    Perkhofer, Lukas
    Mueller, Martin
    Lechel, Andre
    Sainz, Bruno, Jr.
    Hermann, Patrick C.
    Seufferlein, Thomas
    Kleger, Alexander
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (05) : 594 - 606
  • [2] Patient-Derived Organoids Predict Cancer Treatment Response
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14): : 1427 - 1427
  • [3] Utilising patient derived organoids to predict the response to treatment in gastric cancer
    Alam, Mushfique
    Duckworth, Carrie
    Howes, Nathan
    Stephens, Nathan
    Pritchard, Mark
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [4] Establishment of a platform to predict radiation sensitivity in organoids derived from esophageal cancer patients
    Kim, G. Y.
    Jeong, E.
    Lee, D. W.
    Ku, B.
    Choi, S. Y.
    Chung, M. K.
    Oh, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S876 - S876
  • [5] Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response (vol 8, pg 594, 2020)
    Frappart, P. O.
    Walter, K.
    Gout, J.
    Beutel, A. K.
    Morawe, M.
    Arnold, F.
    Breunig, M.
    Barth, T. F.
    Marienfeld, R.
    Schulte, L.
    Ettrich, T.
    Hackert, T.
    Svinarenko, M.
    Rosler, R.
    Wiese, S.
    Wiese, H.
    Perkhofer, L.
    Mueller, M.
    Lechel, A.
    Sainz, B., Jr.
    Hermann, P. C.
    Seufferlein, T.
    Kleger, A.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (08) : 987 - 987
  • [6] The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
    Su, Chang
    Olsen, Kelly A. A.
    Bond, Catherine E. E.
    Whitehall, Vicki L. J.
    CANCERS, 2023, 15 (03)
  • [7] Patient derived cancer organoids predict clinical response for patients with locally advanced rectal cancer
    Udgata, Shirsa
    Sunil, Aishwarya
    Schmitz, Rebecca L.
    Pantha, Barsha
    Gillette, Amani
    Kratz, Jeremy
    Grogan, Patrick
    DeStefanis, Rebecca
    Johnson, Katherine
    Kraus, Sean
    Carchman, Evie
    Lawson, Elise
    Sanger, Christina
    Heise, Charles
    Bassetti, Michael
    Kimple, Randall
    Lemmon, Kayla
    Larson, Morgan
    Pasch, Cheri
    Skala, Melissa
    Deming, Dustin
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Coexisting mechanisms of luminogenesis in pancreatic cancer-derived organoids
    Randriamanantsoa, Samuel J.
    Raich, Marion K.
    Saur, Dieter
    Reichert, Maximilian
    Bausch, Andreas R.
    ISCIENCE, 2024, 27 (07)
  • [9] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
    Wensink, G. Emerens
    Elias, Sjoerd G.
    Mullenders, Jasper
    Koopman, Miriam
    Boj, Sylvia F.
    Kranenburg, Onno W.
    Roodhart, Jeanine M. L.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [10] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
    G. Emerens Wensink
    Sjoerd G. Elias
    Jasper Mullenders
    Miriam Koopman
    Sylvia F. Boj
    Onno W. Kranenburg
    Jeanine M. L. Roodhart
    npj Precision Oncology, 5